Celiac Sprue

Celiac Sprue is a topic covered in the Washington Manual of Medical Therapeutics.

To view the entire topic, please or .

The Washington Manual is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Explore these free sample topics:

-- The first section of this topic is shown below --

General Principles

  • Celiac sprue consists of chronic inflammation of proximal small bowel mucosa from an immunologic sensitivity to gluten (protein found in wheat, barley, and rye), resulting in malabsorption of dietary nutrients. The condition remains incompletely recognized and underdiagnosed.1
  • Clinical presentation can vary greatly from asymptomatic iron deficiency anemia to significant diarrhea and weight loss. Other presenting features can include osteoporosis, dermatitis herpetiformis, abnormal liver enzymes, and abdominal pain; incidental recognition at endoscopy can also occur.1
  • More than 7% of patients with nonconstipated IBS have celiac-associated antibodies, suggesting that gluten sensitivity may trigger symptoms resembling IBS.2

-- To view the remaining sections of this topic, please or --

General Principles

  • Celiac sprue consists of chronic inflammation of proximal small bowel mucosa from an immunologic sensitivity to gluten (protein found in wheat, barley, and rye), resulting in malabsorption of dietary nutrients. The condition remains incompletely recognized and underdiagnosed.1
  • Clinical presentation can vary greatly from asymptomatic iron deficiency anemia to significant diarrhea and weight loss. Other presenting features can include osteoporosis, dermatitis herpetiformis, abnormal liver enzymes, and abdominal pain; incidental recognition at endoscopy can also occur.1
  • More than 7% of patients with nonconstipated IBS have celiac-associated antibodies, suggesting that gluten sensitivity may trigger symptoms resembling IBS.2

There's more to see -- the rest of this topic is available only to subscribers.